Cardinal Health stock holds steady as consensus price targets point higher
Published on 08/31/2026 at 19:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health Inc. (US14149Y1082) stock is quoted at $234.55 on August 31, 2026, with a small intraday decline of 0.25% that leaves the shares comfortably in the mid-$230 range. Recent market data show the move as modest, suggesting investors are taking a measured view of the company following its latest results and guidance.
Valuation gap versus analyst targets
Per data compiled from recent coverage on August 31, 2026, Cardinal Health carries a consensus rating of Moderate Buy, with an average price target of $266.56 for the shares. The latest consensus overview places that $266.56 target more than $30 above the current $234.55 quote, implying upside potential of roughly 13.6% if the company delivers on expectations.
The same August 31, 2026, consensus snapshot also describes the rating as Moderate Buy, indicating that the majority of covering analysts remain positive on the stock while some maintain more neutral views. The recent analyst stance summary underscores that sentiment is constructive but not euphoric, which fits with a share price that has risen toward the mid-$230s without reaching the consensus target band yet.
Market data snapshot and investor positioning
The $234.55 quote shown for Cardinal Health on August 31, 2026, reflects a daily move of -$0.58, or -0.25%, leaving the shares relatively stable compared with broader index moves. The intraday pricing overview also situates the stock within its ongoing trading range, with the modest decline suggesting short-term consolidation rather than a sharp shift in the company story.
Institutional activity reported on August 31, 2026, offers a window into how professional investors are positioning around Cardinal Health. One recent filing highlights a new stake of $2.02 million taken in Cardinal Health, while another filing notes a reduction in holdings by a large asset manager, both recorded with effective dates that align with the latest quarter. The disclosed $2.02 million purchase underscores that some institutions are adding exposure at current levels, even as others trim positions within diversified portfolios.
For investors, the interplay between a $234.55 market price and a $266.56 average price target is central to the near-term thesis. The implied gap of $32.01 per share represents the difference between where the stock trades and where consensus expects it to move over the coming 12 months, assuming earnings and cash flow trends remain aligned with current forecasts. Such a spread is not extreme for a large health care distributor, but it does signal that the market is still discounting some risk or awaiting clearer proof points from upcoming quarterly results.
Business profile and product context
Cardinal Health operates as a major health care services and products company, supplying pharmaceuticals and medical products to hospitals, pharmacies, and other care providers across the United States and internationally. The company focuses on distribution efficiency, inventory management, and clinical product support, aiming to help customers manage costs and maintain reliable access to critical therapies.
Within its product portfolio, Cardinal Health offers a broad range of medical and surgical items, including sterile procedural kits, respiratory care supplies, and laboratory products designed to streamline workflows in clinical settings. These offerings typically serve recurring demand, which can support stable revenue streams and predictable cash flow, but they also expose the business to pricing pressure and contract renegotiations as health systems seek savings.
Shares and current trading level
As of August 31, 2026, Cardinal Health stock trades at $234.55 in regular market activity, denominated in USD. The current quote data frame that price as a modest step down from the prior close, leaving the shares below the $266.56 analyst average price target but within a range that reflects solid performance over recent months.
Fact box
Company: Cardinal Health Inc.
ISIN: US14149Y1082
Ticker: CAH
Exchange: NYSE
Price (as of August 31, 2026, 9:41 a.m. ET): $234.55 USD
Sector / Industry: Health care / Health care distribution
Index membership: S&P 500
Investor Relations
Further details on Cardinal Health, including strategy, segment information, and upcoming events, are available via the companys investor relations page. The corporate site provides background on operations and governance that complements the market data and consensus figures discussed here.
